-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

301.P1.15 301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Coronaviruses, SARS-CoV-2/COVID-19, sickle cell disease, viral, Bleeding and Clotting, Diseases, platelets, Biological Processes, Hemoglobinopathies, Thrombosis, Cell Lineage, Infectious Diseases, Clinically relevant, Thrombotic Disorders, inflammation, Vascular Wall, molecular interactions, pathogenesis, pathways, signal transduction
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Caroline Diorio, MD1, Kevin O McNerney, MD, MSTR2*, Michele P. Lambert, MD, MSTR3, Michele Paessler, D.O.4*, Julie Chase, MD, PhD5*, Kandace Gollomp, MD6, Benjamin L Laskin, MD7*, Laura A Vella, MD, PhD8*, Sarah E Henrickson, MD PhD5*, Emily Liebling, MD5*, Chakkapong Burudpakdee, BS9*, Jessica Lee, BS10*, Fran Balamuth, MD PhD11*, Allison M Blatz, MD5*, Kathleen Chiotos, MD, MSCE12*, Julie C Fitzgerald, MD13*, Therese Giglia, MD, MSCE14*, Audrey R Odom John, MD PhD5*, Whitney Petrosa, CPNP9*, Kathleen Sullivan, MD, PhD15*, Char M Witmer, MD16, Hamid Bassiri, MD/PhD5*, Edward M Behrens, MD5* and David T. Teachey, MD17

1Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
3Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
5Children's Hospital of Philadelphia, Philadelphia, PA
6Department of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
7Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA
8Infectious Disease, Children's Hospital of Philadelphia, Philadelphia, PA
9Immune Dysregulation Frontier Program, Children's Hospital of Philadelphia, Philadelphia, PA
10Immune Dysregulation Frontier Program, Children's Hospital Philadelphia, Philadelphia, PA
11Division of Emergency Medicine, Children's Hospital of Philadelphia, Philadelphia, PA
12Division of Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA
13Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA
14Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA
15Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA
16Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA
17Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and The Perelman School of Medicine at The University of Pennsylvania, Rutledge, PA

Paula M Jacobi1* and Sarah E Sartain, MD2

1Baylor College of Medicine/Texas Children's Hospital, Houston, TX
2Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX

Gowtham K Annarapu, PhD1, Deirdre Nolfi-Donegan, MD2, Anuradha Bharara Singh, PhD1*, Michael Reynolds3* and Sruti Shiva, PhD1,4,5*

1Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
2Pediatric Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA
3University of Pittsburgh, Pittsburgh, PA
4Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA
5Center for Metabolism and Mitochondrial Medicine (C3M), University of Pittsburgh, Pittsburgh, PA

Ana Belen Moreno-Castaño, MD, PhD Student1*, Sara Fernandez, MD2*, Marta Palomo, PhD3*, Patricia Molina, Technician4*, Julia Martinez-Sanchez, PhD Student5*, Sergi Torramade-Moix, PhD Student1*, Helena Ventosa, MD6*, Ferran Segui, MD6*, Gines Escolar, MD, PhD7*, Enric Carreras, MD, PhD5*, Jose Maria Nicolas, MD, PhD8*, Edward Richardson, MD9*, David Garcia-Bernal, PhD10*, Carmelo Carlo-Stella, MD11, Jose Maria Moraleda, MD, PhD12*, Paul G. Richardson, MD13, Maribel Diaz-Ricart1* and Pedro Castro, MD, PhD14*

1Hematopathology, Pathology Department, CDB, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Endothelium Team, Barcelona, Spain., Barcelona, Spain
2Department of Critical Care Medicine, Hospital Clínic of Barcelona, Barcelona, Spain
3Josep Carreras Leukaemia Research Institute, Hospital Clínic of Barcelona, University of Barcelona, Barcelona Endothelium Team (BET), Barcelona, Spain, Barcelona, Spain, Spain
4Hematopathology, Pathology Department, CDB, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain., Barcelona, Spain
5Josep Carreras Leukaemia Research Institute, Hospital Clínic of Barcelona, University of Barcelona, Barcelona Endothelium Team (BET), Barcelona, Spain, Barcelona, Spain
6Department of Critical Care Medicine, Hospital Clínic of Barcelona, Barcelona, Spain, Barcelona, Spain
7Hematopathology, Pathology Department, CDB, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Endothelium Team, Barcelona, Spain., Barcelona, Barcelona, Spain
8Department of Critical Care Medicine, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain, Barcelona, Spain
9Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut, USA; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA, New Haven, CT
10Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain., Murcia, Spain
11Humanitas Cancer Center, Rozzano, Milano, Italy
12Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain, Murcia, Spain
13Dana-Farber Cancer Institute, Boston, MA
14Department of Critical Care Medicine, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona Endothelium Team (BET), Barcelona, Spain, Barcelona, Spain

Tomasz Brzoska, PhD1, Tomasz W. Kaminski, PharmD1, Ravi Vats, MSc1,2, Egemen Tutuncuoglu, MSc1*, Mark T. Gladwin, MD1,3 and Prithu Sundd, PhD1,2,3

1Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA
2Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA
3Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA

*signifies non-member of ASH